Product Name :
Noscapine hydrochloride
Description:
Noscapine hydrochloride ((S, R)-Noscapine hydrochloride) is an orally active phthalideisoquinoline alkaloid with potent antitussive. Noscapine hydrochloride exerts its antitussive effects by activating sigma opioid receptors and is a non-competitive Bradykinin inhibitor. Noscapine hydrochloride disrupts microtubule dynamics, induces mitotic arrest and apoptosis. Noscapine hydrochloride possesses anticancer, neuroprotective, anti-inflammatory activities, and can crosse the blood-brain barrier.
CAS:
912-60-7
Molecular Weight:
449.88
Formula:
C22H24ClNO7
Chemical Name:
(3S)-6, 7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H, 5H, 6H, 7H, 8H-[1, 3]dioxolo[4, 5-g]isoquinolin-5-yl]-1, 3-dihydro-2-benzofuran-1-one hydrochloride
Smiles :
Cl.COC1=C2C(=O)O[C@H]([C@H]3C4=C(OC)C5OCOC=5C=C4CCN3C)C2=CC=C1OC
InChiKey:
MFLVZFXCSKVCSH-URBRKQAFSA-N
InChi :
InChI=1S/C22H23NO7.ClH/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18;/h5-6,9,17-18H,7-8,10H2,1-4H3;1H/t17-,18+;/m1./s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Noscapine hydrochloride ((S, R)-Noscapine hydrochloride) is an orally active phthalideisoquinoline alkaloid with potent antitussive. Noscapine hydrochloride exerts its antitussive effects by activating sigma opioid receptors and is a non-competitive Bradykinin inhibitor. Noscapine hydrochloride disrupts microtubule dynamics, induces mitotic arrest and apoptosis. Noscapine hydrochloride possesses anticancer, neuroprotective, anti-inflammatory activities, and can crosse the blood-brain barrier.|Product information|CAS Number: 912-60-7|Molecular Weight: 449.88|Formula: C22H24ClNO7|Synonym:|(S,R)-Noscapine hydrochloride|Chemical Name: (3S)-6, 7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H, 5H, 6H, 7H, 8H-[1, 3]dioxolo[4, 5-g]isoquinolin-5-yl]-1, 3-dihydro-2-benzofuran-1-one hydrochloride|Smiles: Cl.COC1=C2C(=O)O[C@H]([C@H]3C4=C(OC)C5OCOC=5C=C4CCN3C)C2=CC=C1OC|InChiKey: MFLVZFXCSKVCSH-URBRKQAFSA-N|InChi: InChI=1S/C22H23NO7.ClH/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18;/h5-6,9,17-18H,7-8,10H2,1-4H3;1H/t17-,18+;/m1./s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 125 mg/mL (277.85 mM; Need ultrasonic)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.Bathophenanthroline Biological Activity |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Noscapine (0-1000 μM; 0-96 hours; rat C6 glioma cells) treatment inhibits cell viability of rat C6 glioma in vitro in a dose- and time-dependent manner.X-alpha-Gal site Noscapine inhibits the viability of rat C6 glioma cells with an IC50 of 250 μM at 72 hours.PMID:33351463 Noscapine exposure causes abnormal S-phase reentry, increases mitotic arrest and results in excessive DNA accumulation. Cylindromatosis increases the ability of noscapine to induce mitotic arrest and apoptosis. Cylindromatosis enhances the effect of noscapine on microtubule polymerization and promotes noscapine binding to microtubules.|In Vivo:|Noscapine (300 mg/kg; oral gavage; daily; for 15 days; athymic female mice) treatment reduces tumor growth in mice.|References:|Jaren W Landen, et al. Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth. Clin Cancer Res. 2004 Aug 1;10(15):5187-201.Yang Y, et al. CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism. Theranostics. 2015 Mar 2;5(7):656-666.Vartika Tomar, et al. Noscapine and Its Analogs as Chemotherapeutic Agent: Current Updates. Curr Top Med Chem. 2017;17(2):174-188.Products are for research use only. Not for human use.|
